未登录

Y

Yongbo Kang

Yunnan University

H指数:25

被引数:1,751

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Future prospect of polysaccharide as a potential therapy in hepatocellular carcinoma: A review

多糖作为肝细胞癌潜在治疗的未来展望

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-06-010

PRE

The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum (vol 22, 268, 2024)

CELL COMMUNICATION AND SIGNALING

IF8.9

2024-05-270

OAAI

The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum

CELL COMMUNICATION AND SIGNALING

IF8.9

2024-05-147

OAAI

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota

HEPATOLOGY COMMUNICATIONS

IF4.6

2024-04-014

OAAI

Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-08-0113

OAAI

Hydrogen gas ameliorates acute alcoholic liver injury via anti-inflammatory and antioxidant effects and regulation of intestinal microbiota

氢气通过抗炎、抗氧化和调节肠道菌群改善急性酒精性肝损伤

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-07-0111

PRE

A Novel Synbiotic Alleviates Autoimmune Hepatitis by Modulating the Gut Microbiota-Liver Axis and Inhibiting the Hepatic TLR4/NF-κB/NLRP3 Signaling Pathway

IF4.6

2023-04-2738

OAAI

The Trichinella spiralis-derived antigens alleviate HFD-induced obesity and inflammation in mice

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-04-015

PRE

Editorial: Improve metabolic and autoimmune diseases by regulating gut microbiota

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-291

OAAI

The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies

FRONTIERS IN NUTRITION

IF5.1

2022-09-154

OAAI

Future Prospect of Oral Microbiota Influencing Allergy/Asthma Development

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-05-305

OAAI

Future prospect of Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2022-05-280

OAAI

Commentary: Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral Lactobacillus plantarum

FRONTIERS IN NUTRITION

IF5.1

2022-02-181

OAAI

Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability

嗜酸乳杆菌通过调节肠道菌群失调和肠道通透性改善小鼠肥胖

PHARMACOLOGICAL RESEARCH

IF10.5

2022-01-01129

PRE

The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies

IF9.1

2021-12-2142

OA

Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability

JOURNAL OF NUTRITIONAL BIOCHEMISTRY

IF4.9

2021-12-0156

PREAI

Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer

粪便菌群移植增强免疫检查点抑制剂治疗癌症的疗效

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2021-08-2820

OAAI

Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy

IF3.7

2021-05-2916

OAAI

Epidemiology and Genetic Diversity of Rotavirus in Kunming, China, in 2015

IF1.8

2018-07-0513

OAAI

Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy

肠道菌群和乙型肝炎病毒诱导的慢性肝病: 粪便微生物群移植治疗的意义

JOURNAL OF HOSPITAL INFECTION

IF3.1

2017-08-0144

PREAI